Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Health Catalyst, Inc.
Report date June 01, 2026 · Filed June 03, 2026
Section 16 reporting ended · disclosed 2026-06-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 321,132 |
Reported balance
After 2026-06-01 transaction · row 1
1 source rowRow 1 · 2026-06-01 · Tax withholding · Disposed 8,519 · Balance 321,132 F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2026 Filed Jun 3, 2026 23:46 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 8,519 | $1.37 | $11,672.73 |
DisclosureSEC source: 0001780878-26-000003 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 321,132 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 23:47 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 13,836 | $1.66 | $22,966.38 |
DisclosureSEC source: 0001780878-26-000002 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 329,651 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:06 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 4,471 | $1.75 | $7,814.41 |
DisclosureSEC source: 0001780878-26-000001 · primarydocument.xml · nonDerivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 343,487 F3 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:06 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 13,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001780878-26-000001 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 347,958 F2 · shares: Represents an award of 13,195 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2025. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:06 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 191,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001780878-26-000001 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 334,763 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will vest in 12 equal quarterly installments beginning on March 1st 2026. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 21:19 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 9,762 | $2.90 | $28,311.75 |
DisclosureSEC source: 0001780878-25-000002 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,263 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 22:33 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 2,854 | $3.36 | $9,597.15 |
DisclosureSEC source: 0001562180-25-006100 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,025 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 01:05 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 2,965 | $3.63 | $10,777.18 |
DisclosureSEC source: 0001562180-25-004389 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,879 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 22:21 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 7,525 | $4.58 | $34,442.68 |
DisclosureSEC source: 0001562180-25-002005 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,844 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| February 20, 2025 Filed Feb 25, 2025 01:49 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 11,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-001548 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,369 F2 · shares: Represents an award of 11,750 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2024. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. F3 · balance_after: Excludes 200 shares that were previously reported as held by the Reporting Person due to an inadvertent administrative error. Read SEC document |
| February 20, 2025 Filed Feb 25, 2025 01:49 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 69,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-001548 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,819 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 33.33% of the RSUs will vest on December 1, 2025 and, thereafter, the remaining 66.67% of the RSUs will vest in 8 equal quarterly installments. Read SEC document |
| February 18, 2025 Filed Feb 21, 2025 00:58 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 6,441 | $5.43 | $34,952.73 |
DisclosureSEC source: 0001562180-25-001452 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 85,819 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 12, 2024 in accordance with Rule 10b5-1. Read SEC document |
| January 15, 2025 Filed Jan 18, 2025 01:14 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 6,442 | $5.80 | $37,348.14 |
DisclosureSEC source: 0001562180-25-000429 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,260 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 12, 2024 in accordance with Rule 10b5-1. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 6,442 | $7.88 | $50,793.88 |
DisclosureSEC source: 0001562180-24-008480 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 98,702 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 12, 2024 in accordance with Rule 10b5-1. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 21:05 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 7,766 | $8.97 | $69,685.87 |
DisclosureSEC source: 0001562180-24-008093 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,144 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| November 15, 2024 Filed Nov 18, 2024 21:35 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,365 | $8.50 | $11,602.50 |
DisclosureSEC source: 0001562180-24-007742 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,910 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 12, 2024 in accordance with Rule 10b5-1. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:09 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,324 | $8.16 | $10,803.84 |
DisclosureSEC source: 0001562180-24-007368 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 114,275 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 12, 2024 in accordance with Rule 10b5-1. Read SEC document |
| September 16, 2024 Filed Sep 18, 2024 20:59 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,324 | $8.43 | $11,161.32 |
DisclosureSEC source: 0001562180-24-006866 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,599 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 12, 2024 in accordance with Rule 10b5-1. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 20:41 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 1,613 | $7.27 | $11,725.06 |
DisclosureSEC source: 0001562180-24-006684 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,923 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 21:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,328 | $6.57 | $8,724.96 |
DisclosureSEC source: 0001562180-24-006323 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,536 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 21:22 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,290 | $6.51 | $8,397.90 |
DisclosureSEC source: 0001562180-24-005779 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,864 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1. Read SEC document |
| June 17, 2024 Filed Jun 21, 2024 00:35 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,290 | $6.37 | $8,220.53 |
DisclosureSEC source: 0001562180-24-005208 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,154 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 20:15 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 1,716 | $6.53 | $11,211.14 |
DisclosureSEC source: 0001562180-24-004631 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,444 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| May 15, 2024 Filed May 20, 2024 22:35 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 2,066 | $7.00 | $14,462.00 |
DisclosureSEC source: 0001562180-24-004235 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,160 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 20:31 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 2,005 | $6.11 | $12,250.55 |
DisclosureSEC source: 0001562180-24-003448 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 126,226 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 21:04 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 2,005 | $7.80 | $15,647.62 |
DisclosureSEC source: 0001562180-24-002815 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 128,231 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:14 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 3,439 | $8.05 | $27,688.08 |
DisclosureSEC source: 0001562180-24-002252 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,236 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| February 20, 2024 Filed Feb 23, 2024 00:34 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 3,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-001654 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,675 F2 · shares: Represents an award of 3,889 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2023. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 20, 2024 Filed Feb 23, 2024 00:34 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 65,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-001654 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,786 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 33.33% of the RSUs will vest on December 1, 2024 and, thereafter, the remaining 66.67% of the RSUs will vest in 8 equal quarterly installments. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 21:10 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 3,262 | $9.77 | $31,854.73 |
DisclosureSEC source: 0001562180-24-001434 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,786 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 22:49 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 3,163 | $10.83 | $34,246.12 |
DisclosureSEC source: 0001562180-24-000542 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,048 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 21:07 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 3,163 | $8.83 | $27,922.65 |
DisclosureSEC source: 0001562180-23-008466 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,211 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 22:38 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 4,161 | $7.45 | $31,000.70 |
DisclosureSEC source: 0001562180-23-008134 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,374 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:20 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,196 | $8.25 | $9,867.00 |
DisclosureSEC source: 0001562180-23-007757 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,535 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1. Read SEC document |
| October 16, 2023 Filed Oct 20, 2023 20:04 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,161 | $8.33 | $9,671.13 |
DisclosureSEC source: 0001562180-23-007403 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,731 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 22:09 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,160 | $11.01 | $12,771.60 |
DisclosureSEC source: 0001562180-23-006963 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,892 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1. Read SEC document |
| September 01, 2023 Filed Sep 7, 2023 00:47 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 1,484 | $11.78 | $17,476.33 |
DisclosureSEC source: 0001562180-23-006764 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,052 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| August 22, 2023 Filed Aug 24, 2023 22:29 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 737 | $11.90 | $8,770.30 |
DisclosureSEC source: 0001562180-23-006563 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,536 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 23, 2023 in accordance with Rule 10b5-1. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 23:32 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 1,548 | $11.24 | $17,397.97 |
DisclosureSEC source: 0001562180-23-004861 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,273 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Includes 3,510 shares held by the Reporting Person that were not previously reported due to an inadvertent administrative error. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:09 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 1,734 | $14.29 | $24,776.43 |
DisclosureSEC source: 0001562180-23-002425 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,311 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 21:10 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001831 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,045 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs will vest on December 1, 2023 and, thereafter, the remaining 75% of the RSUs will vest in 12 equal quarterly installments. Read SEC document |
| February 15, 2023 Filed Feb 18, 2023 00:19 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 662 | $13.82 | $9,148.84 |
DisclosureSEC source: 0001562180-23-001536 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,045 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 22:00 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 642 | $12.12 | $7,781.04 |
DisclosureSEC source: 0001562180-23-000516 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,707 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1. Read SEC document |
| December 15, 2022 Filed Dec 20, 2022 00:07 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 642 | $11.00 | $7,063.99 |
DisclosureSEC source: 0001562180-22-008374 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,349 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:38 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 3,557 | $10.65 | $37,880.98 |
DisclosureSEC source: 0001562180-22-008048 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,991 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:12 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 669 | $10.82 | $7,235.57 |
DisclosureSEC source: 0001562180-22-007729 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,548 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1. Read SEC document |
| October 18, 2022 Filed Oct 20, 2022 21:20 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 648 | $9.53 | $6,175.44 |
DisclosureSEC source: 0001562180-22-007297 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,217 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 21:07 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 648 | $10.99 | $7,121.52 |
DisclosureSEC source: 0001562180-22-006734 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,865 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 20:11 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 848 | $11.61 | $9,841.04 |
DisclosureSEC source: 0001562180-22-006495 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,513 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:51 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 668 | $13.14 | $8,777.52 |
DisclosureSEC source: 0001562180-22-006117 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,361 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.